Improving patient adherence to asthma treatments in the United Kingdom
The UK has one of the highest asthma prevalences worldwide
An estimated 22% of UK adults aged 18 to 45 years have wheezing symptoms, and 17% have a doctor diagnosis of asthma
Asthma kills three people each day in the UK - one of the highest death rates for asthma in Europe. 90% of these premature deaths can be prevented
Our clinical team developed evidence-based clinical messages tackling these issues of adherence
We engaged 50% of our UK network (~6k pharmacies) to address this challenge
Pharmacists delivered clinical patient education messages at the point of dispensing the target asthma medication. The messages advised patients on how to get the most out of their treatment
Using data from our pharmacies and comparing to a control set, we were able to measure the trend line-based impact of the programme.
This analysis showed that dispensed volumes of the target asthma medication increased by up to 15% during a five-month pilot patient support programme.
When the full support programme was instigated, dispensed volumes in our active pharmacies grew by up to 35% more than the control (inactive) pharmacies, suggesting the programme had a significant impact on medication compliance.
Impact on Dispensed Volumes